Spero Therapeutics, Inc. (SPRO)
2.365
-0.06
(-2.27%)
USD |
NASDAQ |
Feb 09, 16:00
2.365
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Market Cap : 133.24M for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 11.11B |
| Amicus Therapeutics, Inc. | 4.412B |
| Cassava Sciences, Inc. | 99.27M |
| Omeros Corp. | 800.82M |
| GeoVax Labs, Inc. | 4.659M |
Market Cap Related Metrics
| PS Ratio | 4.482 |
| Price to Book Value | 5.029 |
| Price | 2.365 |
| Earnings Yield | -33.61% |